Carmel, IN, United States of America

Anh-Quan Hannah Nguyen



Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 21(Granted Patents)


Company Filing History:


Years Active: 2017

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in Cancer Treatment by Anh-Quan Hannah Nguyen

Introduction

Anh-Quan Hannah Nguyen is an accomplished inventor based in Carmel, IN (US). She has made significant contributions to the field of cancer treatment through her innovative research and development of pharmaceutical compounds. Her work focuses on targeting specific enzymes that play a crucial role in cancer progression.

Latest Patents

Nguyen holds a patent for her invention titled "Inhibitors of EZH2." This patent relates to compounds that inhibit the activity of the histone lysine methyltransferase, Enhancer of Zeste Homolog 2 (EZH2). The invention includes pharmaceutical compositions comprising these compounds and methods for using them to treat various types of cancer, including hematologic and solid tumors. She has 1 patent to her name.

Career Highlights

Nguyen is currently employed at Eli Lilly and Company, where she continues to advance her research in oncology. Her work has the potential to lead to new therapeutic options for patients suffering from cancer.

Collaborations

Throughout her career, Nguyen has collaborated with notable colleagues, including Deqi Guo and Michael Enrico Richett. These partnerships have fostered a collaborative environment that enhances the innovation process.

Conclusion

Anh-Quan Hannah Nguyen's contributions to cancer treatment through her patent on EZH2 inhibitors exemplify her dedication to improving patient outcomes. Her work at Eli Lilly and Company continues to pave the way for future advancements in oncology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…